The plasma-derived medicine market has experienced significant growth in recent years due to the increasing demand for plasma-derived therapies and the growing prevalence of chronic diseases such as immune deficiencies, bleeding disorders, and neurological conditions. The market is driven by the development of new and advanced plasma-derived therapies, as well as increasing awareness among patients and healthcare providers about the benefits of these treatments. The market is also influenced by factors such as government initiatives to increase the availability of plasma-derived products, advances in manufacturing processes, and increasing investment by key players in research and development. However, the market faces challenges such as the high cost of plasma-derived therapies, strict regulatory guidelines, and the risk of transmission of infectious diseases. Overall, the plasma-derived medicine market is expected to continue its growth trajectory, but will likely face continued challenges and regulatory scrutiny.
The Global Plasma Derived Medicine Market is estimated to be valued at US$ 33,450 million in 2021 and expected to exhibit a CAGR of 6.8% during the forecast period (2021-2028).
Market Players in the Plasma Derived Medicine Industry:
1. Grifols, S.A.
Grifols, S.A. is a Spanish company founded in 1909, with its headquarters in Barcelona, Spain. It operates in more than 100 countries worldwide and is a global leader in the production of plasma-derived medicines. In March, 2023 Grifols announced a global collaboration and licensing agreement with Selagine Inc, a company focused on developing novel therapeutics for ocular diseases, to treat dry eye disease (DED) with immunoglobulin eye drops.
2. SK Plasma
SK Plasma is a South Korean company founded in 2018 and headquartered in Seoul, South Korea. It is a subsidiary of SK Group, and operates in several countries worldwide. In February, 2022 SK Plasma has signed a Memorandum of Understanding (MOU with Egypt’s state-owned pharmaceutical company, Arab Company for Drug Industries and Medical Appliances (ACDIMA) to contract manufacture plasma-derived products and technology transfer.
3. Fusion Healthcare
Fusion Healthcare is an Indian company founded in 2004, with its headquarters in Mumbai, India. It operates in several countries, including India, Bangladesh, and Sri Lanka, and is a leading producer of plasma-derived medicines.
4. Takeda Pharmaceutical Company Limited
Takeda Pharmaceutical Company Limited is a Japanese company founded in 1781, with its headquarters in Tokyo, Japan. It operates in more than 80 countries worldwide and is one of the largest producers of plasma-derived medicines globally. Taked, Zedira and Dr. Falk Pharma GmbH in October, 2022 announced a collaboration and licensing agreement to develop ZED1227/TAK-227, a Phase 2b investigational therapy for the treatment of celiac disease.
5. LFB
LFB is a French company founded in 1994, with its headquarters in Les Ulis, France. It operates in more than 40 countries worldwide and is a leading producer of plasma-derived medicines in Europe.
6. Octapharma AG
Octapharma AG is a Swiss company founded in 1983, with its headquarters in Lachen, Switzerland. It operates in more than 115 countries worldwide and is a major producer of plasma-derived medicines.
7. CSL Limited
CSL Limited is an Australian company founded in 1916, with its headquarters in Melbourne, Australia. It operates in more than 60 countries worldwide and is one of the largest producers of plasma-derived medicines globally. In April 3, 2023 The LFB Group announces today that its subsidiary LFB BIOMANUFACTURING has become a member of France BioLead, the association for the production of biomedicines in France.
8. Bio Products Laboratory Ltd.
Bio Products Laboratory Ltd. is a British company founded in 1950, with its headquarters in Elstree, Hertfordshire, UK. It operates in several countries worldwide and is a leading producer of plasma-derived medicines in the UK.
9. China Biologic Products Holdings, Inc.
China Biologic Products Holdings, Inc. is a Chinese company founded in 2002, with its headquarters in Beijing, China. It operates in more than 100 countries worldwide and is one of the largest producers of plasma-derived medicines in China.
10. Kedrion
Kedrion is an Italian company founded in 2001, with its headquarters in Lucca, Italy. It operates in several countries worldwide and is a leading producer of plasma-derived medicines in Europe.
11. Shanghai RAAS
Shanghai RAAS is a Chinese company founded in 1992, with its headquarters in Shanghai, China. It operates in several countries worldwide and is a major producer of plasma-derived medicines in China.
12. ADMA Biologics Inc.
ADMA Biologics Inc. is a US-based company founded in 2004, with its headquarters in Ramsey, New Jersey. It operates in the US and is a producer of plasma-derived medicines and immunoglobulin therapies.
*Definition- Plasma-derived medicine refers to drugs and therapies that are derived from plasma, the liquid portion of blood. These treatments are used to treat a variety of medical conditions, including immune deficiencies and bleeding disorders.
